OTCMKTS:ENZN Enzon Pharmaceuticals (ENZN) Stock Price, News & Analysis → Beta testers blew this thing up (From Prosper Trading Academy) (Ad) Free ENZN Stock Alerts $0.17 +0.03 (+21.43%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.15▼$0.1750-Day Range$0.06▼$0.2352-Week Range$0.06▼$0.24Volume6,801 shsAverage Volume30,610 shsMarket Capitalization$12.62 millionP/E Ratio17.02Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get Enzon Pharmaceuticals alerts: Email Address Enzon Pharmaceuticals MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.04% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.01Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.21 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Enzon Pharmaceuticals.Read more about Enzon Pharmaceuticals' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.04% of the outstanding shares of Enzon Pharmaceuticals have been sold short.Short Interest Ratio / Days to CoverEnzon Pharmaceuticals has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Enzon Pharmaceuticals has recently increased by 1,568.75%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEnzon Pharmaceuticals does not currently pay a dividend.Dividend GrowthEnzon Pharmaceuticals does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Enzon Pharmaceuticals is 1,200.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Enzon Pharmaceuticals' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ENZN. Previous Next 1.7 News and Social Media Coverage News SentimentEnzon Pharmaceuticals has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Enzon Pharmaceuticals this week, compared to 0 articles on an average week.MarketBeat Follows4 people have added Enzon Pharmaceuticals to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Enzon Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of Enzon Pharmaceuticals is held by insiders.Read more about Enzon Pharmaceuticals' insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Enzon Pharmaceuticals is 17.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.42.Price to Earnings Ratio vs. SectorThe P/E ratio of Enzon Pharmaceuticals is 17.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 177.16. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> About Enzon Pharmaceuticals Stock (OTCMKTS:ENZN)Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.Read More ENZN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENZN Stock News HeadlinesJune 14, 2024 | americanbankingnews.comEnzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Short Interest Up 1,568.8% in MayJune 8, 2024 | americanbankingnews.comReviewing Enzon Pharmaceuticals (OTCMKTS:ENZN) and Genenta Science (NASDAQ:GNTA)November 8, 2023 | morningstar.comEnzon Pharmaceuticals Inc ENZNOctober 25, 2023 | finance.yahoo.comOKYO Pharma Limited (OK10.F)July 30, 2023 | nasdaq.comRegeneron Pharmaceuticals, Inc. Common Stock (REGN)March 26, 2023 | thestreet.comEnzon Stock Hits New 52-Week Low (ENZN)March 20, 2023 | investing.comIbnsina Pharma Co (ISPH)February 26, 2023 | time.comBig Pharma’s Patent Abuses Are Fueling the Drug Pricing CrisisJuly 15, 2022 | morningstar.comEnzon Pharmaceuticals Inc - Stock Operating Performance ENZNJuly 2, 2022 | finance.yahoo.comEnzon Pharmaceuticals, Inc. (ENZN)See More Headlines Receive ENZN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/20/2024Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryBiotechnology Current SymbolOTCMKTS:ENZN Previous SymbolNASDAQ:ENZN CUSIP29390410 CIK727510 Webwww.enzon.com Phone(732) 980-4500Fax732-980-4585EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.01 Trailing P/E Ratio17.02 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.37 million Net MarginsN/A Pretax Margin3,573.08% Return on Equity49.71% Return on Assets3.18% Debt Debt-to-Equity RatioN/A Current Ratio89.19 Quick Ratio89.19 Sales & Book Value Annual Sales$30,000.00 Price / Sales420.58 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares74,220,000Free FloatN/AMarket Cap$12.62 million OptionableNot Optionable Beta0.50 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Richard L. Feinstein CPA (Age 81)CEO, CFO & Secretary Comp: $224.07kKey CompetitorsAffymaxOTCMKTS:AFFYAmgenNASDAQ:AMGNVertex PharmaceuticalsNASDAQ:VRTXRegeneron PharmaceuticalsNASDAQ:REGNGilead SciencesNASDAQ:GILDView All Competitors ENZN Stock Analysis - Frequently Asked Questions How have ENZN shares performed in 2024? Enzon Pharmaceuticals' stock was trading at $0.0936 on January 1st, 2024. Since then, ENZN stock has increased by 81.6% and is now trading at $0.17. View the best growth stocks for 2024 here. Are investors shorting Enzon Pharmaceuticals? Enzon Pharmaceuticals saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 26,700 shares, an increase of 1,568.8% from the May 15th total of 1,600 shares. Based on an average daily volume of 119,100 shares, the short-interest ratio is presently 0.2 days. View Enzon Pharmaceuticals' Short Interest. How were Enzon Pharmaceuticals' earnings last quarter? Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) announced its quarterly earnings data on Wednesday, March, 20th. The biotechnology company reported $0.01 EPS for the quarter. Is Enzon Pharmaceuticals a good dividend stock? Enzon Pharmaceuticals (OTCMKTS:ENZN) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 1,200.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for ENZN. What other stocks do shareholders of Enzon Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Enzon Pharmaceuticals investors own include Aeterna Zentaris (AEZS), CBL & Associates Properties (CBL), Pennsylvania Real Estate Investment Trust (PEI), CNBX Pharmaceuticals (CNBX), Golar LNG Partners (GMLP), Washington Prime Group (WPG), DHT (DHT), Hallador Energy (HNRG) and Medical Marijuana (MJNA). How do I buy shares of Enzon Pharmaceuticals? Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ENZN) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.